Percutaneous Gelled Alcohol Sclerotherapy for Aggressive Angiomas: Evaluation of Feasibility, Safety, and Efficacy
Recruiting
- Conditions
- Bone Angioma
- Interventions
- Other: Collecting data from medical records
- Registration Number
- NCT06607731
- Brief Summary
The investigators aimed to evaluate efficacy and safety of a non-surgical protocol treatment combining transarterial embolization and percutaneous radiopaque gelled ethanol (RGE) sclerotherapy in a first procedure, then followed by vertebroplasty in a second procedure, to treat aggressive vertebral hemangioma patients in tertiary hospital. Exclusion criteria were age \<18-years old and any association with neurological deficit.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
- Every patients treated by gelled alcohol sclerotherapy for aggressive angiomas, in the University Hospital of Saint-Etienne.
Exclusion Criteria
- Patients no treated by gelled alcohol sclerotherapy.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Study population Collecting data from medical records Patients who have undergone percutaneous gel ethanol sclerosis for aggressive bone angioma at Saint-Etienne University Hospital.
- Primary Outcome Measures
Name Time Method Number of complications identified in data collection Day 1 Number of complications identified in data collection
- Secondary Outcome Measures
Name Time Method Number of lesion identified in data collection Day 1 Number of lesion identified in data collection
Trial Locations
- Locations (1)
CHU de Saint-Etienne
🇫🇷Saint-Priest-en-Jarez, France